Hosp Regional Univ de Malaga

The trials here

What the 9 trials at this site are about, from their registry records.

Conditions

• Depression2 trials
• Epilepsy1 trial
• Giant cell arteritis1 trial
• Head and neck cancer1 trial
• Lung cancer1 trial
• Multiple myeloma1 trial
• Prostate cancer1 trial
• Ulcerative colitis1 trial

Phase

• Phase 23 trials
• Phase 33 trials

Status

• Completed4 trials
• Recruiting3 trials
• Active, not recruiting1 trial
• Terminated1 trial

Lead sponsor

• Janssen Research & Development, LLC7 trials
• Janssen-Cilag Ltd.1 trial
• Johnson & Johnson Enterprise Innovation Inc.1 trial

Running trials

• Recruiting

  A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma

  NCT07589634· Phase 2· Janssen Research & Development, LLC· Source

• Recruiting

  A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in a Real-World Setting

  NCT07230691· Janssen Research & Development, LLC· Source

• Recruiting

  JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

  NCT04892173· Phase 3· Johnson & Johnson Enterprise Innovation Inc.· Source

• Active, not recruiting

  A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis

  NCT03596645· Phase 3· Janssen Research & Development, LLC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Head and neck cancer1 recruiting
• Lung cancer1 recruiting
• Multiple myeloma1 recruiting

Closed trials

• Completed

  A Study for the Participants With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated With Androgen Deprivation Therapy (ADT) Plus Apalutamide or Enzalutamide

  NCT05901649· Janssen-Cilag Ltd.· Source

• Completed

  A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)

  NCT05841030· Janssen Research & Development, LLC· Source

• Completed

  A Study of Aticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy

  NCT05455684· Phase 3· Janssen Research & Development, LLC· Source

• Completed

  A Study to Investigate JNJ-40411813 in Combination With Levetiracetam or Brivaracetam in Epilepsy

  NCT04836559· Phase 2· Janssen Research & Development, LLC· Source

• Terminated

  A Study to Evaluate Guselkumab for the Treatment of Participants With New-onset or Relapsing Giant Cell Arteritis

  NCT04633447· Phase 2· Janssen Research & Development, LLC· Source